Legal disclaimer

Last updated 16 November 2026

Please read this disclaimer before relying on anything published on vigi-eye.com. By using the site you accept it, together with our terms of use.

1. General information only

Everything on VigiEye (news, analysis, opinion, calendars, data, newsletters and any other material) is general information for professionals in the pharmaceutical and life-sciences sector. It is not medical, clinical, pharmaceutical, regulatory, legal, tax, financial or investment advice, and it does not create a client, consultancy or any other professional relationship with the publisher or PQRA. Do not act, or refrain from acting, on it without taking advice that fits your own circumstances.

2. Accuracy and official sources

Our stories are drawn from public official records (regulators, official journals, courts and company filings), and each one links to its source. Those records can be updated, corrected or withdrawn after we report them, and summaries can omit detail. We do not warrant that any content is accurate, complete, current or fit for a particular purpose. The official source always prevails: check it before making any regulatory, clinical, commercial or investment decision. Deadlines and dates in particular must be confirmed with the competent authority.

3. Use of artificial intelligence

Content on this site is drafted with the help of AI language models, under the editorial control and responsibility of the publisher (see our editorial policy). AI-assisted text can contain errors, omissions or outdated information. Please tell us about any mistake you find and we will correct it.

4. Medicines and health

Mentions of medicines, medical devices or treatments are news reporting for professionals. They are not advertising or promotion of any product and not a recommendation to prescribe, use or stop using anything. Patients should talk to their doctor or pharmacist. Report suspected side effects to your national medicines authority (in Greece, the EOF at eof.gr).

5. Companies, markets and investments

Reporting or analysis about companies, deals, earnings or the possible effect of news on a company is not an investment recommendation, an offer, or a solicitation to buy or sell any security, and it does not take account of anyone's investment objectives or financial situation. Past performance and our analysis are no guide to future results. Consult an authorised financial adviser before investing.

6. Links, third parties and advertising

Links to official and third-party websites, and advertisements shown on the site (including Google AdSense and PQRA house advertisements), are provided for convenience. We do not control or endorse third-party content, products or services and are not responsible for them.

7. Limitation of liability

To the fullest extent permitted by applicable law, the publisher, PQRA and their staff and contributors are not liable for any direct, indirect, incidental or consequential loss or damage (including loss of profit, revenue, data or business opportunity, regulatory sanctions or missed deadlines) arising from use of, or reliance on, the site or its content, or from the site being unavailable. Nothing in this disclaimer excludes or limits liability that cannot be excluded or limited under applicable law, including liability for intent or gross negligence, or the mandatory rights of consumers.

8. Corrections and complaints

If you believe something we published is inaccurate, unfair or infringes your rights, write to info@pqra.gr with the page address and what you believe is wrong. We review every request promptly, correct or remove material that is wrong, and note material corrections on the page.

9. Publisher information

VigiEye (vigi-eye.com)
Published by Dimitrios Gkikas (trading as PQRA)
Leof. Kifisias 44, 151 25 Marousi, Athens, Greece
VAT number: EL131680720
Email: info@pqra.gr · Phone: +30 21 0444 1982
Editorial responsibility: Dimitrios Gkikas

This disclaimer is governed by Greek law. If any part of it is found unenforceable, the rest remains in effect.